NEXT GENERATION RADIOLIGANDS Trademark

Trademark Overview


On Sunday, November 6, 2022, a trademark application was filed for NEXT GENERATION RADIOLIGANDS with the United States Patent and Trademark Office. The USPTO has given the NEXT GENERATION RADIOLIGANDS trademark a serial number of 97664916. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 16, 2024. This trademark is owned by POINT Biopharma Inc.. The NEXT GENERATION RADIOLIGANDS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
next generation radioligands

General Information


Serial Number97664916
Word MarkNEXT GENERATION RADIOLIGANDS
Filing DateSunday, November 6, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
NOT AVAILABLERADIOLIGANDS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePOINT Biopharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46268

Party NamePOINT Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46268

Trademark Events


Event DateEvent Description
Wednesday, November 9, 2022NEW APPLICATION ENTERED
Wednesday, November 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 21, 2023ASSIGNED TO EXAMINER
Thursday, August 24, 2023NON-FINAL ACTION WRITTEN
Thursday, August 24, 2023NON-FINAL ACTION E-MAILED
Thursday, August 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 20, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, November 20, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, February 14, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 15, 2024NON-FINAL ACTION WRITTEN
Monday, April 15, 2024NON-FINAL ACTION E-MAILED
Monday, April 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 16, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 21, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, April 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER